Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11.62 EUR | +1.71% | +1.44% | -5.99% |
31/05 | SMITH & NEPHEW : EPS cut (2023: +8.0%, 2024: -16.2%) | |
14/05 | European Equities Traded in the US as American Depositary Receipts Nudge Higher in Tuesday Trading | MT |
Strengths
- The earnings growth currently anticipated by analysts for the coming years is particularly strong.
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
Weaknesses
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- For the last few months, analysts have been revising downwards their earnings forecast.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-5.99% | 1.1TCr | - | ||
+13.73% | 13TCr | A- | ||
-4.33% | 835.41Cr | C | ||
+41.80% | 567.43Cr | B+ | ||
-21.94% | 471.78Cr | C | ||
+7.81% | 342.28Cr | C- | ||
-10.26% | 275.74Cr | B- | ||
-10.29% | 210.67Cr | - | - | |
-13.58% | 192.14Cr | - | ||
-27.77% | 167.62Cr | C- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- SN. Stock
- NPW1 Stock
- Ratings Smith & Nephew Plc